Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRicardo Plc Regulatory News (RCDO)

  • This share is currently suspended. It was suspended at a price of 430.00
  • There is currently no data for RCDO

Form 8.5 (EPT/RI) - Ricardo PLC

17 Sep 2025 10:17

Form 8.5 (EPT/RI) - Ricardo PLC

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeRicardo plc
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is Joint Advisor and Joint Broker to Ricardo plc
(d) Date dealing undertaken:16th September 2025
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
Ordinary sharesSales4,877427427

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/AN/AN/AN/AN/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/AN/AN/AN/AN/AN/AN/AN/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/AN/AN/AN/AN/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/AN/AN/AN/A

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure:17th September 2025
Contact name:Abhishek Gawde
Telephone number:+91 9923757332

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
2nd Jan 20254:37 pmRNSHolding(s) in Company
2nd Jan 20257:00 amRNSRicardo completes sale of Ricardo Defense
19th Dec 202411:49 amRNSHolding(s) in Company
18th Dec 202410:48 amRNSDirector/PDMR Shareholding
17th Dec 20243:40 pmRNSDirector/PDMR Shareholding
17th Dec 20243:39 pmRNSHolding(s) in Company
16th Dec 20247:01 amRNSRicardo to acquire E3 Advisory
16th Dec 20247:00 amRNSRicardo divests Ricardo Defense
11th Dec 20242:13 pmRNSHolding(s) in Company
2nd Dec 20245:01 pmRNSHolding(s) in Company
2nd Dec 202411:41 amRNSDirector/PDMR Shareholding
22nd Nov 20241:01 pmRNSDirector/PDMR Shareholding
22nd Nov 202412:51 pmRNSHolding(s) in Company
18th Nov 20243:31 pmRNSDirector/PDMR Shareholding
18th Nov 20242:02 pmRNSHolding(s) in Company - replacement
18th Nov 202412:46 pmRNSDirector/PDMR Shareholding
15th Nov 20244:20 pmRNSResult of AGM
30th Oct 202410:28 amRNSDirector/PDMR Shareholding
28th Oct 20245:29 pmRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSStrategy Update
17th Oct 20248:54 amRNSDirectorate Change
14th Oct 20242:12 pmRNSDirector/PDMR Shareholding
8th Oct 20245:39 pmRNSDirector/PDMR Shareholding
30th Sep 202411:15 amRNSTransaction in Own Shares
17th Sep 202411:04 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSPreliminary Results
3rd Sep 20247:00 amRNSNotice of Results and Investor Presentation
28th Aug 202412:00 pmRNSDirectorate Change
21st Aug 202410:52 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTrading Update
15th Jul 20241:00 pmRNSDirector/PDMR Shareholding
25th Jun 202410:50 amRNSDirectorate Change
12th Jun 20249:30 amRNSDirector/PDMR Shareholding
15th May 20243:20 pmRNSDirector/PDMR Shareholding
13th May 20249:25 amRNSDirector/PDMR Shareholding
3rd May 20247:43 amRNSDirectorate Change
30th Apr 20243:40 pmRNSDirector/PDMR Shareholding
22nd Apr 202411:14 amRNSDirector/PDMR Shareholding
22nd Apr 202411:08 amRNSHolding(s) in Company
11th Apr 20242:51 pmRNSDirector/PDMR Shareholding
3rd Apr 20241:48 pmRNSHolding(s) in Company
15th Mar 20245:30 pmRNSHolding(s) in Company
12th Mar 20245:30 pmRNSDirector/PDMR Shareholding
8th Mar 202410:30 amRNSInvestor Meet Company Webinar
7th Mar 20243:26 pmRNSDirector/PDMR Shareholding
7th Mar 202411:55 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSInterim Results
5th Mar 202410:04 amRNSDirectorate Change
13th Feb 20249:39 amRNSDirector/PDMR Shareholding
6th Feb 202410:14 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.